Come visit the CPP booth at the NCAFP Winter Family Physicians Weekend in Asheville, NC! The conference will be held November 29-December 2, 2018 at the Omni Grove Park Inn. Stop by for some vaccine management resources!
Come visit the CPP booth at the American Academy of Pediatrics (AAP) Experience in Orlando November 2-6, 2018. We will be exhibiting with Nationwide Children’s Hospital in booth # 1007. Stop by to learn more about CPP and take home some vaccine management resources! We look forward to seeing you!
CPP rebates for rebate-eligible CPP members will be coming by mail starting in October! Your rebate is based on vaccine purchases made between July 1, 2017 and June 30, 2018.
If you have any questions or need help determining how to get the most value from your CPP membership, please contact the CPP office at 614-722-2145 or firstname.lastname@example.org.
Visit the CPP booth at the AAFP FMX in New Orleans October 10-13, 2018! Stop by the booth to learn more about CPP and take home some vaccine management resources!
CPP will be exhibiting at the Ohio AAP Annual Meeting on September 21st. Visit us in the vendor area at the Crowne Plaza in Dublin, OH!
CPP is pleased to announce a new partnership with Dynavax, the manufacturer of the newly approved adult hepatitis-B vaccine Heplisav-B® administered as a 2-dose series. (April 2018 MMWR publication of the ACIP recommendation)
Members of CPP who opt-into the Dynavax contract can access discounted pricing on doses of Heplisav-B® purchased through an authorized distributor. For a complete list of authorized distributors, see attached list or call 1-84-HEPLISAV (1-844-375-4728).
Members who are interested in participating in the CPP/Dynavax contract should contact the CPP office at 614-722-2145 or email@example.com to obtain an opt-in form.
If you have any questions, please don’t hesitate to contact us!
For the upcoming 2018-2019 flu vaccination season, the American Academy of Pediatrics is advising parents to choose the flu shot.
In February 2018, ACIP decided to make LAIV4 available for the 2018-2019 flu season, based on indirect study data from the manufacturer suggesting their new formulation would be effective, as well as a review of other published research.
However, upon review of the same data, the AAP recommends children receive the injectable form of the vaccine, which was shown to be more consistently effective against most strains of the flu virus over the past several flu seasons. For those children who would otherwise receive no flu vaccine, the AAP says the nasal spray vaccine can be given as a last resort, though it could leave them at higher risk for flu than if they had received the flu shot.
AAP will publish its formal policy statement on flu prevention and treatment in September.